)
This step-by-step guide will help your patients to administer cutaquig® subcutaneously.
Using an appropriate needle length. A longer needle may be needed to reach the subcutaneous tissue and avoid discomfort).
Using an appropriate needle gauge, A narrower gauge may reduce pain during needle insertion while a broader gauge may decrease resistance, increase the infusion rate, and decrease the infusion time.
Using an appropriate type of medical tape or bandage. To mitigate reactions to certain adhesives, paper or hypoallergenic tape may be needed.
Ensuring a dry needle is used. Do not expose the skin to liquid that is on the needle.
Decreasing infusion volume per site may help to reduce local reactions.
Increasing infusion time may help to decrease burning sensation.
Using gentle massage or applying a warm/cold compress after infusion may help to reduce local reactions.
flexIG is a digital therapy diary that supports patients every step of the way to plan, manage and share vital information about their subcutaneous immunoglobulin (IG) treatment. Check the availability of flexIG in your country.
With flexIG, patients can easily schedule injections and reminders to help them remember to take their treatment.
:quality(80))
flexIG will keep a record of each injection, documenting product details, injections sites, injection durations and comments.
:quality(80))
Patients can enter the time and date of their appointments linked to their immunoglobulin therapy. flexIG will store these details and send them reminders. flexIG will also record any previous appointments that have been inputted.
:quality(80))
Patients have a quick and easy record of all of the injections kept securely in their smartphone. No more remembering or guessing, everything recorded will be there.
:quality(80))
flexIG enables patients to share a PDF report of their injections with their healthcare professional. This can provide valuable insight into patient’s IG treatment routine.
:quality(80))
flexIG has been designed to be simple and easy to use. Patients just need to follow the steps below:
Download the flexIG app from App Store or Google Play.
Select country and input personal details.
Input key information about their condition, medication, planned dose and frequency of injection.
Select injection routine.
:quality(80))
A solution for every patient. Cutaquig® therapy diary helps patient who prefer keeping track of their treatment using a notebook.
IPOPI is a non-profit international organisation and the leading advocate for primary immunodeficiency (PID) patients worldwide working in collaboration with patients, doctors, politicians, regulators, pharmaceutical industry and other relevant stakeholders.
IPOPI is the Association of national PID patient organisations dedicated to improving awareness, access to early diagnosis and optimal treatments for primary immunodeficiency patients worldwide through global collaboration.
Local patient groups that represent the interests of primary immunodeficiencies patients also exist. Consult the list of local organisations here:
Epland, K. et al., A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases. Allergy, Asthma & Clinical Immunology, 2022. 18:87.
This is an international website for cutaquig® and is intended for healthcare professionals outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
IMPORTANT: The information on this website is based on the European Summary of Product Characteristics (EU SmPC).
If you wish to contact Octapharma please use the contact form on our corporate website www.octapharma.com.
